Pharos Indonesia is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Dki Jakarta. The company was founded in 1971. Pharos Indonesia was founded by Dr. Eddy Leksmono and has grown to become one of the leading pharmaceutical companies in Indonesia. The company focuses on the production and distribution of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, and health supplements. Pharos Indonesia operates several branches across the Indonesian archipelago, ensuring a strong local presence and accessibility to its products. The company has expanded its operations beyond Indonesia, establishing a footprint in several Southeast Asian countries. The company's main product lines include cardiovascular, anti-infective, and gastrointestinal medications, as well as vitamins and dietary supplements. Some of its well-known brands include Imboost, a popular immune system booster, and Lactacyd, a feminine hygiene product. Pharos Indonesia collaborates with various international pharmaceutical companies to enhance its product offerings and maintain high standards of quality. The company is a member of several industry associations, including the Indonesian Pharmaceutical Association, which helps it stay updated with industry trends and regulations. With a commitment to improving public health, Pharos Indonesia aims to provide affordable and high-quality healthcare solutions. The company's vision is to be a trusted partner in healthcare, contributing to the well-being of communities across the region.
Headquarters
Permata Hijau
South Jakarta; Jakarta;
Postal Code: 12220
Contact Details: Purchase the PT Pharos Indonesia report to view the information.
Website: http://www.pharos.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service